Correlation Between Benitec Biopharma and Cingulate

Can any of the company-specific risk be diversified away by investing in both Benitec Biopharma and Cingulate at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Benitec Biopharma and Cingulate into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Benitec Biopharma Ltd and Cingulate, you can compare the effects of market volatilities on Benitec Biopharma and Cingulate and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Benitec Biopharma with a short position of Cingulate. Check out your portfolio center. Please also check ongoing floating volatility patterns of Benitec Biopharma and Cingulate.

Diversification Opportunities for Benitec Biopharma and Cingulate

-0.59

Correlation Coefficient

Benitec Biopharma  Cingulate

Excellent diversification

The 3 months correlation between Benitec and Cingulate is -0.59. Overlapping area represents the amount of risk that can be diversified away by holding Benitec Biopharma Ltd and Cingulate in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cingulate and Benitec Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Benitec Biopharma Ltd are associated (or correlated) with Cingulate. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cingulate has no effect on the direction of Benitec Biopharma i.e., Benitec Biopharma and Cingulate go up and down completely randomly.

Pair Corralation between Benitec Biopharma and Cingulate

Given the investment horizon of 90 days Benitec Biopharma Ltd is expected to generate 1.3 times more return on investment than Cingulate. However, Benitec Biopharma is 1.3 times more volatile than Cingulate. It trades about 0.05 of its potential returns per unit of risk. Cingulate is currently generating about -0.04 per unit of risk. If you would invest  1,251  in Benitec Biopharma Ltd on December 29, 2024 and sell it today you would earn a total of  92.00  from holding Benitec Biopharma Ltd or generate 7.35% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Benitec Biopharma Ltd  vs.  Cingulate

Benitec Biopharma

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Benitec Biopharma Ltd are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of rather inconsistent basic indicators, Benitec Biopharma exhibited solid returns over the last few months and may actually be approaching a breakup point.

Cingulate

Risk-Adjusted Performance

Very Weak

Over the last 90 days Cingulate has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders.

Pair Trading with Benitec Biopharma and Cingulate

The main advantage of trading using opposite Benitec Biopharma and Cingulate positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Benitec Biopharma position performs unexpectedly, Cingulate can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cingulate will offset losses from the drop in Cingulate's long position.

The idea behind Benitec Biopharma Ltd and Cingulate pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.